Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on May 8, 2024, at 4:30 p.m. Eastern Time to discuss financial results and operations.

SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- Airbnb, Inc. (NASDAQ: ABNB) today announced that the company's first quarter 2024 financial results will be released after market close on Wednesday, May 8, 2024. The company's shareholder letter will be made available on the Airbnb Investor Relations website at https://investors.airbnb.com.

American Battery Technology Company Publishes Updated Initial Assessment and Economic Analysis for its Tonopah Flats Lithium Project for One of the Largest Identified Lithium Resources in the U.S.